Apr 20, 2020 - Novartis (NVS) announces FDA's approval to evaluate hydroxychloroquine in hospitalized patients with COVID-19 in a late-stage study. The company is evaluating several of its drugs to treat COVID-19.
Apr 20, 2020 - Incyte (INCY) gets FDA approval for Pemazyre for the treatment of previously-treated, unresectable, locally-advanced or metastatic cholangiocarcinoma.
Apr 17, 2020 - SLB earnings call for the period ending March 31, 2020.
Apr 15, 2020 - ASML earnings call for the period ending March 29, 2020.
Apr 15, 2020 - TomTom NV (OTCPK:TMOAF) Q1 2020 Results Earnings Conference Call April 15, 2020 08:00 AM ET Company Participants Claudia Janssen - Head, IR Harold Goddijn - CEO Taco Titulaer - CFO Conference Call Par
Apr 15, 2020 - The following slide deck was published by Tomtom NV in conjunction with their 2020 Q1 earnings call.
Apr 14, 2020 - Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.
Apr 08, 2020 - The FDA stretches the review timeline of Roche's (RHHBY) NDA for risdiplam by three months, which is being evaluated to treat spinal muscular atrophy. A decision is now pending on Aug 24, 2020.
Apr 07, 2020 - The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Apr 07, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM